Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02799043 · ClinicalTrials.gov registry record · NA
Randomized Evaluation of Redo Ablation Procedures of Atrial Fibrillation With FIRM Guided Procedures
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 269
- Enrollment target
NCT02799043 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 269 participants.
The verdict
NCT02799043, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 269 participants
- Enrollment target
Study Summary
A prospective, multicenter, randomized study to assess the safety and effectiveness of FIRM-guided procedures in conventional "redo" RF ablation procedures for the treatment of persistent and paroxysmal atrial fibrillation.
Interventions
- PROCEDURE FIRM-Guided Procedure and PVI
- PROCEDURE Standard PVI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 269 participants |
| Start Date | 2016-06 |
| Est. Completion | 2020-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02799043
The ClinicalTrials.gov registry entry for NCT02799043 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 269 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which FIRM-Guided Procedure and PVI is the first listed.
NCT02799043 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02799043 about?
NCT02799043 is a clinical study titled "Randomized Evaluation of Redo Ablation Procedures of Atrial Fibrillation With FIRM Guided Procedures". A prospective, multicenter, randomized study to assess the safety and effectiveness of FIRM-guided procedures in conventional "redo" RF ablation procedures for the treatment of persistent and paroxysmal atrial fibrillation.
What is the current status of trial NCT02799043?
This trial is currently completed. It is a NA study. The enrollment target is 269 participants. The study started on 2016-06. Estimated completion is 2020-07.
What interventions are being tested in trial NCT02799043?
The interventions under investigation include: FIRM-Guided Procedure and PVI (PROCEDURE), Standard PVI (PROCEDURE).
Who is sponsoring clinical trial NCT02799043?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.